| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |